BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37396416)

  • 1. Renal Function and Clinical Outcomes Among Elderly Patients With Nonvalvular Atrial Fibrillation From ANAFIE.
    Shimizu W; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    JACC Asia; 2023 Jun; 3(3):475-487. PubMed ID: 37396416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Anticoagulants in Very Elderly Nonvalvular Atrial Fibrillation Patients With High Bleeding Risks: ANAFIE Registry.
    Okumura K; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    JACC Asia; 2022 Nov; 2(6):720-733. PubMed ID: 36444326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Subcohort Study.
    Koretsune Y; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    JACC Asia; 2023 Aug; 3(4):595-607. PubMed ID: 37614535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study.
    Terauchi Y; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Shimizu W
    Cardiovasc Diabetol; 2023 Jul; 22(1):175. PubMed ID: 37438827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function.
    Lee SR; Choi EK; Han KD; Jung JH; Cha MJ; Oh S; Lip GYH
    Stroke; 2019 Jun; 50(6):1480-1489. PubMed ID: 31084339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.
    Ikeda T; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    J Cardiol; 2023 May; 81(5):441-449. PubMed ID: 36427691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between creatinine clearance and clinical outcomes in Chinese emergency patients with atrial fibrillation.
    Wang J; Zhang T; Yang YM; Zhu J; Zhang H; Shao XH
    Ann Noninvasive Electrocardiol; 2022 May; 27(3):e12942. PubMed ID: 35239203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Wang Y; Li L; Wei Z; Lu S; Liu W; Zhang J; Feng J; Wang D
    Medicines (Basel); 2023 Jan; 10(1):. PubMed ID: 36662497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry.
    Yoshimoto T; Toyoda K; Ihara M; Inoue H; Yamashita T; Suzuki S; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Maruyama H; Teramukai S; Kimura T; Morishima Y; Takita A; Yamaguchi T
    Stroke; 2022 Aug; 53(8):2549-2558. PubMed ID: 35440169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the Renal Function and Adverse Clinical Events in Patients with Atrial Fibrillation: A Japanese Multicenter Registry Substudy.
    Yuzawa Y; Kuronuma K; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Oiwa K; Matsumoto M; Kojima T; Haruta H; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Okubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A; On Behalf Of The Sakura Af Registry Investigators
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry.
    Yamashita T; Suzuki S; Inoue H; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A
    Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):202-213. PubMed ID: 33822030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.
    Bohula EA; Giugliano RP; Ruff CT; Kuder JF; Murphy SA; Antman EM; Braunwald E
    Circulation; 2016 Jul; 134(1):24-36. PubMed ID: 27358434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Cancer on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation - Substudy of the ANAFIE Registry.
    Ikeda T; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Inoue H
    Circ J; 2022 Jan; 86(2):202-210. PubMed ID: 34853279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function.
    Lee SR; Choi EK; Han KD; Jung JH; Oh S; Lip GYH
    Stroke; 2019 May; 50(5):1140-1148. PubMed ID: 30913984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.
    Stanifer JW; Pokorney SD; Chertow GM; Hohnloser SH; Wojdyla DM; Garonzik S; Byon W; Hijazi Z; Lopes RD; Alexander JH; Wallentin L; Granger CB
    Circulation; 2020 Apr; 141(17):1384-1392. PubMed ID: 32160801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the degree of renal dysfunction and the safety and efficacy outcomes in patients with atrial fibrillation receiving direct oral anticoagulants.
    Wada R; Shinohara M; Nakanishi R; Kinosihita T; Yuzawa H; Ikeda T
    J Arrhythm; 2021 Feb; 37(1):88-96. PubMed ID: 33664890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum.
    Carbone A; Bottino R; Attena E; Parisi V; Conte M; D'Andrea A; Imbalzano E; Alfredo C; Russo V
    Cardiovasc Drugs Ther; 2023 Dec; ():. PubMed ID: 38108919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study.
    Lip GYH; Al-Saady N; Ezekowitz MD; Banach M; Goette A
    Am Heart J; 2017 Nov; 193():16-22. PubMed ID: 29129251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
    Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):59-68. PubMed ID: 28950373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.